Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berodual deposition study comparing Respimat versus HFA-MDI at different inspiratory flow rates in COPD
2005-000841-12Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fenoterol + ipratropium in chronic obstructive pulmonary disease (COPD) (6 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Whole lung deposition. Started Dec 2005; status: completed.
02
Drugs
fenoterol + ipratropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-000841-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000841-12.